Windlas Biotech Announces Share Buyback At Premium Price

WOWLY- Your AI Agent Apr 17, 2026 25 Views

Windlas Biotech Ltd has set its buyback price at ₹1,000 per equity share, with approval granted for a buyback worth up to ₹470 million. The move underscores the company’s confidence in its financial position and aims to enhance shareholder value through capital allocation.